For: | Leodolter A, Nocon M, Kulig M, Willich SN, Malfertheiner P, Labenz J. Gastro esophageal reflux disease is associated with absence from work: Results from a prospective cohort study. World J Gastroenterol 2005; 11(45): 7148-7151 [PMID: 16437662 DOI: 10.3748/wjg.v11.i45.7148] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i45/7148.htm |
Number | Citing Articles |
1 |
R. C. V. da Silva, C. C. de Sá, Á. O. Pascual-Vaca, L. H. de Souza Fontes, F. A. M. Herbella Fernandes, R. A. Dib, C. R. Blanco, R. A. Queiroz, T. Navarro-Rodriguez. Increase of lower esophageal sphincter pressure after osteopathic intervention on the diaphragm in patients with gastroesophageal reflux. Diseases of the Esophagus 2013; 26(5): 451 doi: 10.1111/j.1442-2050.2012.01372.x
|
2 |
|
3 |
Ravishankar Jayadevappa, Sumedha Chhatre, Mark Weiner. Gastro-oesophageal acid-related disease, co-morbidity and medical care cost. Chronic Illness 2008; 4(3): 209 doi: 10.1177/1742395308092817
|
4 |
Catarina Jansson, Michael Wiberg, Kristina Alexanderson. Sickness absence due to gastroesophageal reflux diagnoses: a nationwide Swedish population-based study. Scandinavian Journal of Gastroenterology 2013; 48(1): 17 doi: 10.3109/00365521.2012.737359
|
5 |
Josep Darbà, Lisette Kaskens, Pedro Plans, Jose Ignasi Elizalde, Montserrat Coma, Rosario Cuomo, Luigi Santoiemma, Jan Geldmacher. Epidemiology and societal costs of gastroesophageal reflux disease and Barrett’s syndrome in Germany, Italy and Spain. Expert Review of Pharmacoeconomics & Outcomes Research 2011; 11(2): 225 doi: 10.1586/erp.11.5
|
6 |
Joachim Labenz, Sebastian F. Schoppmann. Improving treatment of people with gastro-esophageal reflux disease refractory to proton pump inhibitors. Communications Medicine 2024; 4(1) doi: 10.1038/s43856-024-00632-6
|
7 |
M. NOCON, T. KEIL, S. N. WILLICH. Prevalence and sociodemographics of reflux symptoms in Germany – results from a national survey. Alimentary Pharmacology & Therapeutics 2006; 23(11): 1601 doi: 10.1111/j.1365-2036.2006.02924.x
|
8 |
Rafael Corrêa Vieira da Silva, Tomás Navarro-Rodríguez, Ángel Oliva Pascual-Vaca, Cleofás Rodríguez Blanco. La enfermedad por ref ujo gastroesofágico y la unión esofagogástrica. Revisión de la literatura. Osteopatía Científica 2010; 5(3): 84 doi: 10.1016/S1886-9297(10)70016-3
|
9 |
K. MONKEMULLER, H. NEUMANN, M. NOCON, M. VIETH, J. LABENZ, S. N. WILLICH, M. STOLTE, M. HOCKER, D. JASPERSEN, T. LIND, P. MALFERTHEINER. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro‐oesophageal reflux disease: a matched case–control study. Alimentary Pharmacology & Therapeutics 2008; 28(4): 491 doi: 10.1111/j.1365-2036.2008.03769.x
|
10 |
M. Rezailashkajani, D. Roshandel, S. Shafaee, M.R. Zali. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran. Digestive and Liver Disease 2008; 40(6): 412 doi: 10.1016/j.dld.2008.01.014
|